Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Bioequivalence of Drugs: Drugs with Multiple Indications

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...

Dose-Response Relationship: Potency and Efficacy

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...

Relative Risk

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...

Ratio Level of Measurement

Ratio Level of Measurement

The way a set of data is measured is called its level of measurement. Correct statistical procedures depend on a researcher being familiar with levels of measurement. For analysis, data are classified into four levels of measurement—nominal, ordinal, interval, and ratio.
A set of data measured using the ratio scale takes care of the ratio problem and provides complete information. Ratio scale data are like interval scale data, except they have a zero point and ratios can be calculated. For...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lipoprotein(a) lipidome and chronic kidney disease: Enrichment in triacylglycerols and diacylglycerols.

Journal of clinical lipidology·2026

Same author

Authors' Response to Comments by Di Tanna et al.

Statistics in medicine·2026

Same author

Lipoprotein(a) lipidome and diet: responses to reducing saturated fat intake in African Americans in a randomized trial.

Journal of lipid research·2026

Same author

Prevalence of undiagnosed hypertension and risk assessment using a validated survey in community-based screening in Amman, Jordan.

PloS one·2026

Same author

Meta-Analysis of Cost-Effectiveness.

Statistics in medicine·2026

Same author

Dietary and Physical Activity Habits of Potential Living Kidney Donors.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2026

Search research articles

Related Experiment Video

Updated: May 13, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Median-Based Incremental Cost-Effectiveness Ratio (ICER).

Heejung Bang¹, Hongwei Zhao

¹Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, CA, USA.

Journal of Statistical Theory and Practice

|February 27, 2013

Summary

This summary is machine-generated.

This study introduces the median-based incremental cost-effectiveness ratio (ICER) as a complementary tool to the mean-based ICER in cost-effectiveness analysis (CEA). Considering both measures enhances confidence in evaluating healthcare interventions.

Keywords:

cost-effectiveness analysis cost-effectiveness plane mean cost median cost

More Related Videos

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

Published on: April 19, 2024

Related Experiment Videos

Last Updated: May 13, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

Published on: April 19, 2024

Area of Science:

Health economics
Decision sciences
Biostatistics

Background:

Cost-effectiveness analysis (CEA) is crucial in health sciences for evaluating healthcare strategies.
The incremental cost-effectiveness ratio (ICER) is a popular metric in CEA, but typically relies on mean values.
Cost data in CEA are often skewed, making mean-based measures potentially misleading.

Purpose of the Study:

To propose and validate a median-based ICER as an alternative or complementary measure in CEA.
To provide inferential procedures for the median-based ICER.
To advocate for the simultaneous consideration of mean and median-based ICERs for robust decision-making.

Main Methods:

Development of a median-based ICER methodology.
Introduction of inferential procedures for the median-based ICER.
Comparative analysis of mean-based and median-based ICERs.

Main Results:

The study proposes the median-based ICER, addressing limitations of mean-based measures for skewed cost data.
Inferential procedures are developed to support the use of the median-based ICER.
The paper suggests using both mean and median-based ICERs together.

Conclusions:

Considering both mean and median-based ICERs in CEA provides a more comprehensive assessment of cost-effectiveness.
Concordance between mean and median ICERs increases confidence in results; discordance warrants further investigation.
This approach enhances informed decision-making in healthcare evaluations.